Evidence map›Paper›PMID 40051884›Full record

ArticleJAC-antimicrobial resistance2025

Molecular epidemiology and patient outcome of carbapenem-resistant

Sho Saito, Aki Sakurai, Yasufumi Matsumura, Kohei Uemura, Ryota Hase, Hideaki Kato, Naoya Itoh, Takehiro Hashimoto, Takashi Matono, Jiefu Yu and 18 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Sho SaitoDisease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku 162-8655, Tokyo, Japan.
Aki SakuraiDisease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku 162-8655, Tokyo, Japan.
Yasufumi MatsumuraDepartment of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID https://orcid.org/0000-0001-8595-8944
Kohei UemuraBiostatistics and Bioinformatics Course, The University of Tokyo, Tokyo, Japan.
Ryota HaseDepartment of Infectious Diseases, Japanese Red Cross Narita Hospital, Chiba, Japan.
Hideaki KatoInfection Prevention and Control Department, Yokohama City University Hospital, Kanagawa, Japan.ORCID https://orcid.org/0000-0002-7853-5721
Naoya ItohDivision of Infectious Diseases, Aichi Cancer Center Hospital, Aichi, Japan.ORCID https://orcid.org/0000-0001-6269-7884
Takehiro HashimotoHospital Infection Control Center, Oita University Hospital, Oita, Japan.
Takashi MatonoDepartment of Infectious Diseases, Aso Iizuka Hospital, Fukuoka, Japan.
Jiefu YuAMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Kayoko HayakawaDisease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku 162-8655, Tokyo, Japan.
Masahiro SuzukiDepartments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan.
Shoki IzumiBiostatistics and Bioinformatics Course, The University of Tokyo, Tokyo, Japan.
Tetsuya SuzukiDisease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku 162-8655, Tokyo, Japan.
Mari KurokawaDepartments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan.
Koh ShinoharaDepartment of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID https://orcid.org/0000-0001-8934-0375
Keiichiro MoriDepartment of Clinical Laboratory, Kyoto University Hospital, Kyoto, Japan.
Yasunobu EndoDepartment of Laboratory Medicine, Japanese Red Cross Narita Hospital, Chiba, Japan.
Haruki MitoDepartment of Infectious Diseases, Japanese Red Cross Narita Hospital, Chiba, Japan.
Kayoko SanoClinical Laboratory Department, Yokohama City University Hospital, Kanagawa, Japan.
Tomo MatsunagaClinical Laboratory Department, Yokohama City University Hospital, Kanagawa, Japan.
Nana AkazawaDivision of Infectious Diseases, Aichi Cancer Center Hospital, Aichi, Japan.
Kazufumi HiramatsuHospital Infection Control Center, Oita University Hospital, Oita, Japan.
Yusuke AsaiAMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Shinya TsuzukiAMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5732-846X
David van DuinDivision of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0003-4784-3227
Norio OhmagariDisease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku 162-8655, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4622-8970
Yohei DoiDepartments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan.ORCID https://orcid.org/0000-0002-9620-2525

Funding

Colistin-resistant Acinetobacter baumanniiR01AI104895 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI, ERNST, ROBERT K · 2014 to 2024
$4.2M
Mechanisms of cefiderocol resistanceR21AI151362 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2020 to 2021
$420k
NIAID NIH HHS R01 AI104895NIAID NIH HHS R21 AI151362
6 · The paper itself

Abstract

Background and objectives: Carbapenem-resistant Gram-negative bacilli (CRGNB), especially Methods: Between 2019 and 2022, 246 unique patients with carbapenem-resistant Results: A total of 246 isolates were collected from 246 patients, including 78 (31.7%) CRE, 167 (67.9%) CRPA and 1 (0.4%) CRAB. For CRE, 74.4% of the isolates carried carbapenemase genes with predominance of Conclusions: Our study highlights the unique molecular epidemiology and clinical outcomes of CRGNB in Japan.

Identifiers

PMID40051884
PMCPMC11882498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.